Cargando…

Metabolic Signaling to Epigenetic Alterations in Cancer

Cancer cells reprogram cellular metabolism to support the malignant features of tumors, such as rapid growth and proliferation. The cancer promoting effects of metabolic reprogramming are found in many aspects: generating additional energy, providing more anabolic molecules for biosynthesis, and reb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung-Ae, Yeom, Young Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746039/
https://www.ncbi.nlm.nih.gov/pubmed/29212308
http://dx.doi.org/10.4062/biomolther.2017.185
_version_ 1783289030306168832
author Kim, Jung-Ae
Yeom, Young Il
author_facet Kim, Jung-Ae
Yeom, Young Il
author_sort Kim, Jung-Ae
collection PubMed
description Cancer cells reprogram cellular metabolism to support the malignant features of tumors, such as rapid growth and proliferation. The cancer promoting effects of metabolic reprogramming are found in many aspects: generating additional energy, providing more anabolic molecules for biosynthesis, and rebalancing cellular redox states in cancer cells. Metabolic pathways are considered the pipelines to supply metabolic cofactors of epigenetic modifiers. In this regard, cancer metabolism, whereby cellular metabolite levels are greatly altered compared to normal levels, is closely associated with cancer epigenetics, which is implicated in many stages of tumorigenesis. In this review, we provide an overview of cancer metabolism and its involvement in epigenetic modifications and suggest that the metabolic adaptation leading to epigenetic changes in cancer cells is an important non-genetic factor for tumor progression, which cooperates with genetic causes. Understanding the interaction of metabolic reprogramming with epigenetics in cancers may help to develop novel or highly improved therapeutic strategies that target cancer metabolism.
format Online
Article
Text
id pubmed-5746039
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Society of Applied Pharmacology
record_format MEDLINE/PubMed
spelling pubmed-57460392018-01-01 Metabolic Signaling to Epigenetic Alterations in Cancer Kim, Jung-Ae Yeom, Young Il Biomol Ther (Seoul) Invited Review Cancer cells reprogram cellular metabolism to support the malignant features of tumors, such as rapid growth and proliferation. The cancer promoting effects of metabolic reprogramming are found in many aspects: generating additional energy, providing more anabolic molecules for biosynthesis, and rebalancing cellular redox states in cancer cells. Metabolic pathways are considered the pipelines to supply metabolic cofactors of epigenetic modifiers. In this regard, cancer metabolism, whereby cellular metabolite levels are greatly altered compared to normal levels, is closely associated with cancer epigenetics, which is implicated in many stages of tumorigenesis. In this review, we provide an overview of cancer metabolism and its involvement in epigenetic modifications and suggest that the metabolic adaptation leading to epigenetic changes in cancer cells is an important non-genetic factor for tumor progression, which cooperates with genetic causes. Understanding the interaction of metabolic reprogramming with epigenetics in cancers may help to develop novel or highly improved therapeutic strategies that target cancer metabolism. The Korean Society of Applied Pharmacology 2018-01 2017-12-07 /pmc/articles/PMC5746039/ /pubmed/29212308 http://dx.doi.org/10.4062/biomolther.2017.185 Text en Copyright ©2018, The Korean Society of Applied Pharmacology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Invited Review
Kim, Jung-Ae
Yeom, Young Il
Metabolic Signaling to Epigenetic Alterations in Cancer
title Metabolic Signaling to Epigenetic Alterations in Cancer
title_full Metabolic Signaling to Epigenetic Alterations in Cancer
title_fullStr Metabolic Signaling to Epigenetic Alterations in Cancer
title_full_unstemmed Metabolic Signaling to Epigenetic Alterations in Cancer
title_short Metabolic Signaling to Epigenetic Alterations in Cancer
title_sort metabolic signaling to epigenetic alterations in cancer
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746039/
https://www.ncbi.nlm.nih.gov/pubmed/29212308
http://dx.doi.org/10.4062/biomolther.2017.185
work_keys_str_mv AT kimjungae metabolicsignalingtoepigeneticalterationsincancer
AT yeomyoungil metabolicsignalingtoepigeneticalterationsincancer